Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Tschirdewahn

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Biomedicines|March 25, 2022
Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial CarcinomaPetra Terézia Kovács, Tamás Mayer, Anita Csizmarik, et al.
Urologic Oncology|May 13, 2014
Prognostic effect of serum and tissue YKL-40 levels in bladder cancerStephan Tschirdewahn, Henning Reis, Christian Niedworok, et al.
International Journal of Cancer|January 17, 2019
Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinomaStephan Tschirdewahn, Andrej Panic, Lukas Püllen, et al.
The Journal of Urology|October 11, 2015
Circulating and Tissue Expression Levels of YKL-40 in Renal Cell CancerFrank Vom Dorp, Stephan Tschirdewahn, Christian Niedworok, et al.
Diagnostics (Basel, Switzerland)|January 5, 2021
MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer PatientsTibor Szarvas, Michèle J Hoffmann, Csilla Olah, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 22, 2024
Bricker versus Wallace ureteroileal anastomosis: A multi-institutional propensity score-matched analysisMulham Al-Nader, Ulrich Krafft, Jochen Hess, et al.
Arab Journal of Urology|January 11, 2024
Risk factors for ureteroenteric stricture after radical cystectomy and urinary diversion: A systematic reviewOsama Mahmoud, Ulrich Krafft, Mulham Al-Nader, et al.
Radiation Oncology (London, England)|April 2, 2022
Dosimetric feasibility of moderately hypofractionated/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacerDalia Ahmad Khalil, Danny Jazmati, Dirk Geismar, et al.
Urologia Internationalis|June 28, 2018
The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate CancerChristopher Darr, Ulrich Krafft, Boris Hadaschik, et al.
Urologic Oncology|May 5, 2019
Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancerUlrich Krafft, Stephan Tschirdewahn, Jochen Hess, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Biomedicines|March 25, 2022
Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial CarcinomaPetra Terézia Kovács, Tamás Mayer, Anita Csizmarik, et al.
Urologic Oncology|May 13, 2014
Prognostic effect of serum and tissue YKL-40 levels in bladder cancerStephan Tschirdewahn, Henning Reis, Christian Niedworok, et al.
International Journal of Cancer|January 17, 2019
Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinomaStephan Tschirdewahn, Andrej Panic, Lukas Püllen, et al.
The Journal of Urology|October 11, 2015
Circulating and Tissue Expression Levels of YKL-40 in Renal Cell CancerFrank Vom Dorp, Stephan Tschirdewahn, Christian Niedworok, et al.
Diagnostics (Basel, Switzerland)|January 5, 2021
MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer PatientsTibor Szarvas, Michèle J Hoffmann, Csilla Olah, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 22, 2024
Bricker versus Wallace ureteroileal anastomosis: A multi-institutional propensity score-matched analysisMulham Al-Nader, Ulrich Krafft, Jochen Hess, et al.
Arab Journal of Urology|January 11, 2024
Risk factors for ureteroenteric stricture after radical cystectomy and urinary diversion: A systematic reviewOsama Mahmoud, Ulrich Krafft, Mulham Al-Nader, et al.
Radiation Oncology (London, England)|April 2, 2022
Dosimetric feasibility of moderately hypofractionated/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacerDalia Ahmad Khalil, Danny Jazmati, Dirk Geismar, et al.
Urologia Internationalis|June 28, 2018
The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate CancerChristopher Darr, Ulrich Krafft, Boris Hadaschik, et al.
Urologic Oncology|May 5, 2019
Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancerUlrich Krafft, Stephan Tschirdewahn, Jochen Hess, et al.
Pageof 5